The Contribution of the Intestinal Microbiota to the Celiac Disease Pathogenesis along with the Effectiveness of Probiotic Therapy
- PMID: 38137992
- PMCID: PMC10745538
- DOI: 10.3390/microorganisms11122848
The Contribution of the Intestinal Microbiota to the Celiac Disease Pathogenesis along with the Effectiveness of Probiotic Therapy
Abstract
The development of many human disorders, including celiac disease (CD), is thought to be influenced by the microbiota of the gastrointestinal tract and its metabolites, according to current research. This study's goal was to provide a concise summary of the information on the contribution of the intestinal microbiota to the CD pathogenesis, which was actively addressed while examining the reported pathogenesis of celiac disease (CD). We assumed that a change in gluten tolerance is formed under the influence of a number of different factors, including genetic predisposition and environmental factors. In related investigations, researchers have paid increasing attention to the study of disturbances in the composition of the intestinal microbiota and its functional activity in CD. A key finding of our review is that the intestinal microbiota has gluten-degrading properties, which, in turn, may have a protective effect on the development of CD. The intestinal microbiota contributes to maintaining the integrity of the intestinal barrier, preventing the formation of a "leaky" intestine. On the contrary, a change in the composition of the microbiota can act as a significant link in the pathogenesis of gluten intolerance and exacerbate the course of the disease. The possibility of modulating the composition of the microbiota by prescribing probiotic preparations is being considered. The effectiveness of the use of probiotics containing Lactobacillus and Bifidobacterium bacteria in experimental and clinical studies as a preventive and therapeutic agent has been documented.
Keywords: celiac disease; gluten; gluten enteropathy; gut microbiota; immune response; intestinal permeability; probiotics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Probiotics in Celiac Disease.Nutrients. 2018 Nov 23;10(12):1824. doi: 10.3390/nu10121824. Nutrients. 2018. PMID: 30477107 Free PMC article. Review.
-
Gut Microbiota in Celiac Disease: Is There Any Role for Probiotics?Front Immunol. 2020 May 15;11:957. doi: 10.3389/fimmu.2020.00957. eCollection 2020. Front Immunol. 2020. PMID: 32499787 Free PMC article. Review.
-
Efficacy of probiotics supplementation in amelioration of celiac disease symptoms and enhancement of immune system.World J Clin Cases. 2023 Nov 16;11(32):7741-7744. doi: 10.12998/wjcc.v11.i32.7741. World J Clin Cases. 2023. PMID: 38073702 Free PMC article.
-
Decrease in lactobacilli in the intestinal microbiota of celiac children with a gluten-free diet, and selection of potentially probiotic strains.Can J Microbiol. 2015 Jan;61(1):32-7. doi: 10.1139/cjm-2014-0472. Can J Microbiol. 2015. PMID: 25438612
-
Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?Nutrients. 2015 Aug 17;7(8):6900-23. doi: 10.3390/nu7085314. Nutrients. 2015. PMID: 26287240 Free PMC article. Review.
Cited by
-
A comprehensive review on probiotics and their use in aquaculture: Biological control, efficacy, and safety through the genomics and wet methods.Heliyon. 2024 Dec 4;10(24):e40892. doi: 10.1016/j.heliyon.2024.e40892. eCollection 2024 Dec 30. Heliyon. 2024. PMID: 39735631 Free PMC article. Review.
-
Lactiplantibacillus plantarum Moderating Effect on Autoimmune Celiac Disease Triggers.Probiotics Antimicrob Proteins. 2025 Aug;17(4):2536-2549. doi: 10.1007/s12602-025-10514-5. Epub 2025 Mar 19. Probiotics Antimicrob Proteins. 2025. PMID: 40106190 Review.
-
Integrated Analysis of the Transcriptome and Microbial Diversity in the Intestine of Miniature Pig Obesity Model.Microorganisms. 2024 Feb 10;12(2):369. doi: 10.3390/microorganisms12020369. Microorganisms. 2024. PMID: 38399773 Free PMC article.
-
Reducing Immunoreactivity of Gluten Peptides by Probiotic Lactic Acid Bacteria for Dietary Management of Gluten-Related Diseases.Nutrients. 2024 Mar 27;16(7):976. doi: 10.3390/nu16070976. Nutrients. 2024. PMID: 38613010 Free PMC article.
References
-
- Chen Q., Dong L., Li Y., Liu Y., Xia Q., Sang S., Wu Z., Xiao J., Liu L., Liu L. Research advance of non-thermal processing technologies on ovalbumin properties: The gelation, foaming, emulsification, allergenicity, immunoregulation and its delivery system application. Crit. Rev. Food Sci. Nutr. 2023:1–22. doi: 10.1080/10408398.2023.2179969. - DOI - PubMed
-
- Leiby J.S., McCormick K., Sherrill-Mix S., Clarke E.L., Kessler L.R., Taylor L.J., Hofstaedter C.E., Roche A.M., Mattei L.M., Bittinger K., et al. Lack of detection of a human placenta microbiome in samples from preterm and term deliveries. Microbiome. 2018;6:196. doi: 10.1186/s40168-018-0575-4. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources